EWA
TEVA icon

EverSource Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

EverSource Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.3K Sell
748
-910
-55% -$30.3K ﹤0.01% 2262
2026
Q1 		$49.9K Buy
1,658
+647
+64% +$20.8K ﹤0.01% 1885
2025
Q4 		$31.5K Buy
1,011
+345
+52% +$8.5K ﹤0.01% 2071
2025
Q3 		$13.5K Buy
666
+17
+3% +$299 ﹤0.01% 2648
2025
Q2 		$10.9K Sell
649
-212
-25% -$3.42K ﹤0.01% 2755
2025
Q1 		$13.2K Sell
861
-8,304
-91% -$148K ﹤0.01% 1946
2024
Q4 		$202K Buy
9,165
+8,542
+1,371% +$155K 0.01% 651
2024
Q3 		$11.2K Hold
623
– – ﹤0.01% 1797
2024
Q2 		$10.9K Sell
623
-518
-45% -$7.98K ﹤0.01% 1808
2024
Q1 		$16K Sell
1,141
-4,500
-80% -$56.7K ﹤0.01% 1469
2023
Q4 		$58.9K Sell
5,641
-2,500
-31% -$23.3K 0.01% 834
2023
Q3 		$83K Sell
8,141
-749
-8% -$6.97K 0.01% 638
2023
Q2 		$66.9K Sell
8,890
-3,341
-27% -$27.1K 0.01% 723
2023
Q1 		$108K Buy
12,231
+449
+4% +$4.44K 0.01% 521
2022
Q4 		$107K Buy
11,782
+10,396
+750% +$90.7K 0.02% 486
2022
Q3 		$11K Buy
1,386
+887
+178% +$7.84K ﹤0.01% 1113
2022
Q2 		$3K Hold
499
– – ﹤0.01% 1436
2022
Q1 		$5K Buy
499
+305
+157% +$2.54K ﹤0.01% 1292
2021
Q4 		$2K Buy
+194
New +$1.75K ﹤0.01% 1631

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

EverSource Wealth Advisors's TEVA Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Teva Pharmaceuticals (TEVA) stake by 55% in Q2 2026, selling an estimated $30.3K and leaving 748 shares worth $25.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2262.

EverSource Wealth Advisors first reported a position in TEVA in Q4 2021 and has held it in 19 quarters since. The position peaked at $202K in Q4 2024. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • EverSource Wealth Advisors held 748 shares of Teva Pharmaceuticals worth $25.3K as of Q2 2026.
  • EverSource Wealth Advisors sold 910 Teva Pharmaceuticals shares in Q2 2026, an estimated $30.3K.
  • Teva Pharmaceuticals made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2262 holding.
  • EverSource Wealth Advisors first reported a position in Teva Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • EverSource Wealth Advisors's Teva Pharmaceuticals position peaked at $202K in Q4 2024.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.